Here is the latest stock price and chart of ZYDUS LIFESCIENCES. For more details, see the ZYDUS LIFESCIENCES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
LIVE NOW: Watch as We Reveal the Details of This Potential Crorepati- Making Stock... for FREE!
Live BSE Quotes | May 24, 2022 (Close) | ||
---|---|---|---|
Price (Rs)368.15 | Open (Rs) 365.00 | High (Rs) 373.55 | Low (Rs) 360.15 |
% Change1.59 | Volume 92,243 | Value (Rs) 33,843,220 | 52-Week H/L 668.85 / 319.40 |
Live NSE Quotes | May 24, 2022 3:29:58 PM | ||
---|---|---|---|
Price (Rs)368.90 | Open (Rs) 364.50 | High (Rs) 373.65 | Low (Rs) 360.25 |
% Change1.77 | Volume 3,217,497 | Value (Rs) 1,182,365,798 | 52-Week H/L 673.70 / 342.85 |
Change | |||||
---|---|---|---|---|---|
1 Day 1.59% | 1 Month 7.91% | 3 Months 6.97% | 1 Year -40.75% | 5 Years (CAGR)* -3.54% | 10 Years (CAGR)* -6.83% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* 22.82 | P/E Ratio (x) 16.13 | Market Cap (Rs m) 376,890.84 | P/BV (x) 2.90 | Dividend Yield (%) 0.95 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
ZYDUS LIFESCIENCES last traded price was up 1.6% to Rs 368.2 on the BSE. On the NSE, ZYDUS LIFESCIENCES last traded price was up 1.8% to Rs 368.9. The total volume of shares traded was 3.3 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.4%. And the benchmark S&P BSE SENSEX was at 54,052.6 (down 0.4%).
Over the last 30 days, the ZYDUS LIFESCIENCES share price is up 7.9%. And over the last one year, ZYDUS LIFESCIENCES share price is down 40.7%.
The current market capitalisation of ZYDUS LIFESCIENCES stands at Rs 376,890.84 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of March 2022, company promoters held 74.88% stake in ZYDUS LIFESCIENCES, with no shares having been pledged. To know more, check out the latest shareholding pattern of ZYDUS LIFESCIENCES.
What else is happening in the markets today? Dig in...
Indian share markets ended on a negative note today as global cues remained weak.
A look into the company's quarter four financial performance.
These companies are likely to benefit the most from Covid-19 vaccines.
Here's why Divi's Lab's stock fell over 10% in two days.
For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.
During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.
More Views on NewsWe are just two months into 2022 and several penny stocks that we track have already surged 5x.
Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.
A step-by-step method to pick the best penny stocks for the long term.
These penny stocks can become future multibaggers. Watch out for them.
Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?
More